STIM
Neuronetics Q3 2026 revenue up 12.5% to $42.0M
Neuronetics reported strong Q3 2026 results with total revenue up 12.5%, despite a net loss of $1.6 million, as both NeuroStar device sales and Greenbrook clinic operations showed year-over-year growth.